The long-awaited EU Biotech Act proposal, aimed at boosting Europe’s innovation capacity, will be submitted by the end of the year, EU Health Commissioner Olivér Várhelyi said on Thursday.

Avak Kahvejian, PhD, a general partner with biotech incubator Flagship Pioneering, discusses how AI is rearchitecting methods ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is among the most promising biotech stocks to buy according to hedge funds.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is among the most promising biotech stocks to buy according to hedge funds. According to a recent disclosure with the SEC, Assenagon Asset Management S.A.

German biotech company Repairon GmbH announced the completion of a Series A round of financing that will enable further clinical development of its groundbreaking regenerative heart failure therapy.

A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

Symbio Bioculinary does not concern submission combat or landscaping businesses, it upcycles food waste to tackle the over 30 ...

A Rockville clinical-stage biotech has closed a $50 million Series B round to advance its potential treatments for cancer and ...

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be ...

French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: Agios ...

A drug developer planning to seek FDA approval for its first drug before the end of the year has signed a 32,000-square-foot ...